ERIKA BALBUENA: Open Payments
NPI 1326724881 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,319 in 57 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $1,757 · 2025 $1,319
Food & beverage: $1,319
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $198 |
| AstraZeneca Pharmaceuticals LP | 7 | $151 |
| Novo Nordisk Inc | 7 | $149 |
| ABBVIE INC. | 5 | $90 |
| PFIZER INC. | 4 | $79 |
| Seqirus USA Inc | 3 | $66 |
| Phathom Pharmaceuticals, Inc. | 3 | $66 |
| Lundbeck LLC | 3 | $65 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Inspire Medical Systems, Inc. | 2 | $58 |
Products named: REPATHA, Rybelsus, FARXIGA, VOQUEZNA, REXULTI, CAPVAXIVE, INSPIRE, ELIQUIS.
Industry payments across IL — which companies pay providers there.
